Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Marrone Bio Innovations, Inc. (MBII)

0.7981   -0.202 (-20.19%) 12-31 19:00
Open: 1.01 Pre. Close: 1
High: 1.02 Low: 0.747
Volume: 7,393,697 Market Cap: 146(M)

Technical analysis

as of: 2022-11-18 4:22:31 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.06     One year: 1.19
Support: Support1: 0.74    Support2: 0.62
Resistance: Resistance1: 0.91    Resistance2: 1.01
Pivot: 0.79
Moving Average: MA(5): 0.79     MA(20): 0.79
MA(100): 0.81     MA(250): 0.84
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 18.7     %D(3): 18.7
RSI: RSI(14): 31.4
52-week: High: 1.25  Low: 0.55
Average Vol(K): 3-Month: 7,394 (K)  10-Days: 7,394 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MBII ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 77 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.02 - 1.03 1.03 - 1.03
Low: 0.74 - 0.74 0.74 - 0.75
Close: 0.79 - 0.8 0.8 - 0.81

Company Description

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Headline News

Thu, 10 Nov 2022
Milwaukee Ballet unveils $5 million campaign to make new 'Nutcracker' - Milwaukee Journal Sentinel

Tue, 08 Nov 2022
Ghana: Golf - Mbii Win GCB Bank's 2nd Classic Medal - AllAfrica - Top Africa News

Tue, 26 Jul 2022
To Earn a Bremont Mbi, You Must Face Death - Road & Track

Mon, 11 Jul 2022
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp. - GlobeNewswire

Mon, 11 Jul 2022
Marrone Bio Innovations shareholders approve merger deal with Bioceres Crop Solutions - Seeking Alpha

Wed, 11 May 2022
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Basic Materials
Industry:  Agricultural Inputs
Shares Out. 181 (M)
Shares Float 89 (M)
% Held by Insiders 1.2 (%)
% Held by Institutions 67.6 (%)
Shares Short 1,810 (K)
Shares Short P.Month 3,120 (K)

Stock Financials

EPS -0.14
EPS Est Next Qtl -0.21
EPS Est This Year -1.01
EPS Est Next Year -0.57
Book Value (p.s.) 0.18
Profit Margin (%) -47.1
Operating Margin (%) -43.8
Return on Assets (ttm) -15
Return on Equity (ttm) -71.8
Qtrly Rev. Growth 0.5
Gross Profit (p.s.) 0.15
Sales Per Share 0.24
EBITDA (p.s.) -0.09
Qtrly Earnings Growth 0
Operating Cash Flow -13 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -5.92
PEG Ratio -0.4
Price to Book value 4.2
Price to Sales 3.25
Price to Cash Flow -10.82

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.